Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community
- PMID: 30104087
- PMCID: PMC6837129
- DOI: 10.1016/j.aprim.2018.06.004
Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community
Abstract
Aim: To determine the patterns of antibiotic susceptibility of Escherichia coli strains isolated from adult patients with urinary tract infection (UTI), and to stratify the results by age and type of UTI to verify if there are statistically significant differences that can help physicians to prescribe better empirical antibiotherapy.
Design: Cross-sectional prospective study.
Location: Community of Getafe (Madrid). Primary care level.
Participants: 100 E. coli strains, randomly chosen, isolated from the urine (104-105cfu/ml) of different patients from primary care centers in the Getafe area.
Main measurements: The antibiotic susceptibility of the strains was evaluated and the results were stratified by age and type of UTI. The clinical and demographic data of the patients were analyzed, classifying each episode as complicated UTI or uncomplicated UTI.
Results: Strains isolated from patients with uncomplicated UTI showed significantly greater susceptibility than those of complicated UTI to amoxicillin (65.9% vs. 30.6%, p=0.001), amoxicillin/clavulanic acid (95.5% vs. 77.6%, p=0.013) and ciprofloxacin (81.8% vs. 63.3%, p=0.047). In complicated UTI, susceptibility to ciprofloxacin was significantly greater in the ≤65 years age group compared to the older age group (78.3% vs. 50%, respectively, p=0.041). In the rest of antibiotics, no statistically significant differences were obtained when comparing by age (≤65 years versus >65 years), both in uncomplicated and complicated UTI.
Conclusions: Clinical and demographic data of patients with UTI are of great importance in the results of the antibiotic susceptibility in E. coli. Antibiograms stratified by patient characteristics may better facilitate empirical antibiotic selection for UTI in primary care.
Objetivo: Determinar los patrones de sensibilidad antibiótica de cepas de Escherichia coli aisladas de pacientes adultos con infección del tracto urinario (ITU), y estratificar los resultados por edad y tipo de ITU para verificar si existen diferencias estadísticamente significativas que puedan ayudar a los médicos a la prescripción de una mejor antibioterapia empírica.
Diseño: Estudio transversal prospectivo.
Emplazamiento: Comunidad de Getafe (Madrid). Nivel de atención primaria.
Participantes: 100 cepas de E. coli, escogidas al azar, aisladas de orina (104 ->105 ufc/ml) de diferentes pacientes de centros de atención primaria del área de Getafe.
Mediciones principales: Se evaluó la sensibilidad antibiótica de las cepas y los resultados se estratificaron por edad y tipo de ITU. Se analizaron los datos clínicos y demográficos de los pacientes de los que provenían, clasificándose cada episodio como ITU complicada o ITU no complicada.
Resultados: Las cepas aisladas de pacientes con ITU no complicada mostraron una sensibilidad antibiótica significativamente mayor que las de ITU complicada a amoxicilina (65,9% vs. 30,6%, p = 0.001), amoxicilina/clavulánico (95,5% vs. 77,6%, p = 0.013) y ciprofloxacino (81,8% vs. 63,3%, p = 0.047). En la ITU complicada, la sensibilidad al ciprofloxacino fue significativamente mayor en el grupo de edad ≤65 años en comparación con el grupo de mayor edad (78,3% vs. 50%, p = 0.041). Para el resto de antibióticos no se observaron diferencias significativas cuando se compararon por edad (≤65 versus >65), tanto en ITU no complicada como complicada.
Conclusiones: Los datos clínicos y demográficos de los pacientes con ITU son de gran importancia en los resultados de la sensibilidad antibiótica en E. coli. Los antibiogramas estratificados por características de los pacientes podrían facilitar una mejor selección de antibioterapia empírica para las ITU en atención primaria.
Keywords: Antimicrobial resistance; Escherichia coli; Infecciones del tracto urinario; Resistencia a antibióticos; Urinary tract infections.
Copyright © 2018 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.J Antimicrob Chemother. 2005 Nov;56(5):914-8. doi: 10.1093/jac/dki344. Epub 2005 Sep 20. J Antimicrob Chemother. 2005. PMID: 16174685
-
The Role of Stratified Cumulative Antibiograms in the (Choice of Appropriate Antibiotics in Urinary Tract Infection) Management of Urinary Tract Infections.Pathogens. 2025 Feb 3;14(2):141. doi: 10.3390/pathogens14020141. Pathogens. 2025. PMID: 40005518 Free PMC article.
-
Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period.Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2151-2158. doi: 10.1007/s10096-019-03655-3. Epub 2019 Aug 22. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31440915 Free PMC article.
-
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.Dan Med Bull. 2011 Apr;58(4):B4187. Dan Med Bull. 2011. PMID: 21466767 Review.
-
Etiologic and Anti-microbial Susceptibility Profiles of Bacterial Urinary Tract Infection and Bacterial Enteritis among Children at a Private Multi-Specialty Healthcare Facility in Abuja, Nigeria: A 5-Year Separate and Comparative Review.Niger J Clin Pract. 2024 Jan 1;27(1):35-46. doi: 10.4103/njcp.njcp_299_23. Epub 2024 Feb 5. Niger J Clin Pract. 2024. PMID: 38317033 Review.
Cited by
-
Trends in Incidence and Outcomes of Hospitalizations for Urinary Tract Infection among Older People in Spain (2001-2018).J Clin Med. 2021 May 26;10(11):2332. doi: 10.3390/jcm10112332. J Clin Med. 2021. PMID: 34073638 Free PMC article.
-
Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain.Microbiol Spectr. 2022 Jun 29;10(3):e0004122. doi: 10.1128/spectrum.00041-22. Epub 2022 May 23. Microbiol Spectr. 2022. PMID: 35604206 Free PMC article.
-
Antimicrobial Activity of Apis mellifera Bee Venom Collected in Northern Peru.Antibiotics (Basel). 2023 Apr 19;12(4):779. doi: 10.3390/antibiotics12040779. Antibiotics (Basel). 2023. PMID: 37107142 Free PMC article.
References
-
- Keating K.N., Perfetto E.M., Subedi P. Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs. Expert Rev Pharmaeconomic Outcomes Res. 2005;5:457–466. - PubMed
-
- Llor C., Hernández S. Enfermedad infecciosa en atención primaria: estudio prospectivo efectuado durante todo un año. Enferm Infecc Microbiol Clin. 2010;28:222–226. - PubMed
-
- Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103-e120. - PubMed
-
- McNulty C.A., Richards J., Livermore D.M., Little P., Charlett A., Freeman E. Clinical relevance of laboratory reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother. 2006;58:1000–1008. - PubMed
-
- Naber K.G., Schito G., Botto H., Palou J., Mazzei T. Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. Eur Urol. 2008;54:1164–1178. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical